MetLife Investment Management LLC lessened its holdings in MetLife, Inc. (NYSE:MET - Free Report) by 4.0% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 152,966 shares of the financial services provider's stock after selling 6,340 shares during the quarter. MetLife Investment Management LLC's holdings in MetLife were worth $12,617,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently bought and sold shares of MET. MeadowBrook Investment Advisors LLC boosted its position in shares of MetLife by 244.4% during the 3rd quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider's stock worth $26,000 after acquiring an additional 220 shares in the last quarter. Carmichael Hill & Associates Inc. lifted its stake in MetLife by 131.9% during the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider's stock worth $27,000 after purchasing an additional 186 shares during the last quarter. Wolff Wiese Magana LLC boosted its holdings in MetLife by 374.3% in the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider's stock valued at $29,000 after purchasing an additional 277 shares in the last quarter. Peterson Financial Group Inc. purchased a new position in MetLife in the third quarter valued at approximately $30,000. Finally, Fortitude Family Office LLC raised its holdings in MetLife by 177.3% during the third quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider's stock worth $34,000 after purchasing an additional 266 shares in the last quarter. 89.81% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several research analysts have recently issued reports on MET shares. Bank of America lowered their target price on shares of MetLife from $99.00 to $96.00 and set a "buy" rating for the company in a report on Thursday, August 1st. Jefferies Financial Group upped their price objective on shares of MetLife from $89.00 to $95.00 and gave the company a "buy" rating in a research note on Friday, September 27th. TD Cowen lifted their target price on MetLife from $97.00 to $99.00 and gave the stock a "buy" rating in a research report on Wednesday. Barclays decreased their target price on MetLife from $91.00 to $90.00 and set an "overweight" rating for the company in a research report on Thursday, October 31st. Finally, Morgan Stanley cut their price target on MetLife from $86.00 to $85.00 and set an "overweight" rating on the stock in a research report on Monday, August 19th. Fourteen analysts have rated the stock with a buy rating, According to MarketBeat.com, MetLife currently has a consensus rating of "Buy" and an average target price of $88.62.
View Our Latest Stock Analysis on MET
MetLife Price Performance
Shares of NYSE MET opened at $88.25 on Thursday. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16. The company has a market cap of $61.11 billion, a PE ratio of 17.79, a P/E/G ratio of 0.79 and a beta of 1.05. The stock has a fifty day moving average price of $83.05 and a 200 day moving average price of $76.37. MetLife, Inc. has a 1-year low of $62.89 and a 1-year high of $89.05.
MetLife Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Tuesday, November 5th will be issued a $0.545 dividend. This represents a $2.18 annualized dividend and a dividend yield of 2.47%. The ex-dividend date of this dividend is Tuesday, November 5th. MetLife's payout ratio is 43.95%.
MetLife Company Profile
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.